Articles From: - NICE Positioned as a Leader by Gartner in the Magic Quadrant for Customer Engagement Center Workforce Optimization to - AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc


Evaluation based on completeness of vision and ability to execute RA'ANANA, Israel , November 17, 2014 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced it has been positioned by Gartner, Inc. in the "leaders" quadrant of the "2014 Magic Quadrant for Customer Engagement Center Workforce Optimization." [1] NICE was recognized by Gartner for its completeness of vision and ability to execute, based on the criteria listed in the report.
Sign-up for - NICE Positioned as a Leader by Gartner in the Magic Quadrant for Customer Engagement Center Workforce Optimization investment picks
2014/11/17
NASDAQ: CRME TSX: COM VANCOUVER , Nov.
Sign-up for 2014/11/17 - Cardiome Enters Commercialization Agreement with Aspen for BRINAVESS® in South Africa investment picks
2014/11/17
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced they will present data from their Phase 3 study, "BOW015, a Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses: 54-Week Results of a Randomized, Double-Blind, Active Comparator Study,” at the 2014 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals (ACR/ARHP), November 18, in Boston, MA.
Sign-up for 2014/11/17 - Data from EPIRUS’ Phase 3 Study of BOW015, a biosimilar infliximab, to be Presented as a Late Breaking Poster at the American College of Rheumatology Annual Meeting investment picks
The board of directors of Exterran Holdings, Inc. (NYSE:EXH) announced today that it has unanimously authorized management to pursue a plan to separate the company's international contract operations, international aftermarket services and global fabrication businesses into a standalone, publicly traded company (SpinCo), resulting in two independent companies.
Sign-up for - Exterran Holdings, Inc. Announces Plan to Separate Its International and Fabrication Businesses Into a New Publicly Traded Company investment picks
Raytheon's accelerated milestone powered by Agile development TEWKSBURY, Mass.
Sign-up for - Air & Missile Defense Radar software - and targets - on track investment picks
2014/11/17
Great Canadian Named Executive Adopts Automatic Securities Disposition and/or Purchase Plans Canada NewsWire RICHMOND, BC , Nov.
Sign-up for 2014/11/17 - Great Canadian Named Executive Adopts Automatic Securities Disposition and/or Purchase Plans investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979272001&sourceType=1 http://media3.marketwire.com/logos/20130226-kelt.jpg CALGARY, ALBERTA --
Sign-up for - Kelt Provides 2015 Financial and Operating Guidance investment picks
1U/2U/4U GPU Servers Support New Tesla K80 GPUs, New Ultra Architecture Maximizes Performance, Density and Efficiency with 160W CPUs, GPU/Xeon Phi Support, 100Gb/s EDR IB, NVMe and Titanium Level Power Supplies NEW ORLEANS , Nov.
Sign-up for - Supermicro® Exhibits the Industry's Broadest Range of HPC Optimized Platforms and New Ultra SuperServer® Solutions at Supercomputing '14 investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced a licensing agreement for Dicerna to use Tekmira’s proprietary lipid nanoparticle (LNP) technology for delivery of DCR-PH1, Dicerna’s investigational product candidate for primary hyperoxaluria type 1 (PH1), a rare, inherited liver disorder that often results in kidney failure, and for which there are no approved therapies.
Sign-up for - Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159608&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for - JDSU Responds to Sandell Asset Management investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026417-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/14/11G026417/amarin-184007589553.jpg BEDMINSTER, NJ and DUBLIN, IE--(Marketwired - November 17, 2014) - Amarin Corporation Plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today the presentation of new data and related analyses from the MARINE and ANCHOR phase 3 studies.
Sign-up for - Amarin Announces Presentation of MARINE and ANCHOR Analyses at the American Heart Association Scientific Sessions Showing Vascepa(R) Significantly Reduced Remnant-Like Particle Cholesterol in Hypertriglyceridemic Patients investment picks
2014/11/17
GOLDEN, Colo.
Sign-up for 2014/11/17 - Atna Announces Sale of Reward and Clover Properties for US$10.0 Million investment picks
http://media.marketwire.com/attachments/201411/81715_Capture.JPG http://media.marketwire.com/attachments/201411/81693_extreme.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158364&ProfileId=051205&sourceType=1 BOSTON, MA --
Sign-up for - Sanbolic Joins Extreme Networks' Global Technology Solution Partner Program to Promote Innovations Addressing Today's Network Challenges investment picks
2014/11/17
Find out where you can recycle in your area MILWAUKEE , Nov.
Sign-up for 2014/11/17 - Give your car battery another life investment picks
http://media.marketwire.com/attachments/201411/288808_Lynx-Color-Logo.jpg http://media.marketwire.com/attachments/201411/81799_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159138&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for - Lynx Software Technologies Announces Security Critical RTOS Support for Curtiss-Wright's VPX6-187 Platform investment picks
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ESB Financial Corp.
Sign-up for - SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of ESB Financial Corp. in Connection with the Sale of the Company investment picks
Sevion Therapeutics, Inc. ("Sevion" or the "Company") (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today reported financial results for the fiscal quarter ended September 30, 2014 (“First Quarter 2015”). "During the first fiscal quarter of 2015, we made a strategic decision to focus our efforts and resources on our proprietary antibody discovery technology platforms, including two promising antibodies that are advancing toward IND status,” said Ronald Martell, Chief Executive Officer of Sevion.
Sign-up for - Sevion Therapeutics Reports First Quarter 2015 Financial Results investment picks
Nate’s Food Co.
Sign-up for - Nate’s Food Co. Announces Product Sells Out Within 20 minutes investment picks
2014/11/17
WILMINGTON, Del.
Sign-up for 2014/11/17 - ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Baker Hughes Incorporated (“Baker Hughes” or the “Company”) (NYSE: BHI) relating to the proposed buyout of the Company by Halliburton Company (“Halliburton”). On November 17, 2014, Baker Hughes and Halliburton announced the signing of a definitive agreement pursuant to which Halliburton will acquire Baker Hughes in a transaction valued at approximately $34.6 billion.
Sign-up for - SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Baker Hughes Incorporated And Encourages Investors To Contact The Firm For Additional Information investment picks
- Transaction Valued at $66 Billion or $219 per Share in Cash and Actavis Shares - - Fastest Growing, Most Dynamic Pharmaceutical Company in Global Healthcare - - Leading Blockbuster Franchises in Ophthalmology, Neurosciences/CNS, Medical Aesthetics/Dermatology/Plastic Surgery, Women's Health, Gastroenterology and Urology - - Positioned for Long-Term Double-Digit Organic Revenue and Earnings Growth - - Double-Digit Accretion to Non-GAAP EPS within First 12 Months - - Expands International Presence with Greater Market and Product Reach - - Projected Synergies of at Least $1.8 Billion while Maintaining R&D Commitment of Approximately $1.7 Billion - - Free Cash Flow Generation of more than $8 Billion expected in 2016 - - Investment Grade Rating Expected to be Maintained; Rapid Deleveraging to Below 3.5x Debt to Adjusted EBITDA within 12 Months - - Closing Anticipated in Q2 2015 - DUBLIN and IRVINE, Calif.
Sign-up for - Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue investment picks
2014/11/17
Levi & Korsinsky is investigating the Board of Directors of Valley Financial Corporation (“Valley Financial” or “the Company”) (NasdaqCM: VYFC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to BNC Bancorp.
Sign-up for 2014/11/17 - VYFC SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Valley Financial Corporation Regarding the Fairness of the Sale of the Company to BNC Bancorp investment picks
MeetMe, Inc. (NASDAQ: MEET) today announced it ranked No.
Sign-up for - MeetMe Ranked Number 3 Fastest Growing Internet Company in North America on Deloitte’s 2014 Technology Fast 500™ investment picks
2014/11/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979245001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg TORONTO, ONTARIO --
Sign-up for 2014/11/17 - BMO Financial Group Announces Estimated Annual Reinvested Distributions for BMO Exchange Traded Funds investment picks
Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today announced the Company closed three first mortgage loans totaling $290 million.
Sign-up for - Apollo Commercial Real Estate Finance, Inc. Closes Three First Mortgage Loans Totaling $290 Million investment picks
SAN JOSE, Calif.
Sign-up for - Maxim Integrated To Present At Upcoming Investor Conferences investment picks
Company Announces Intelligent, High Performance Data Center Switching, Analytics and the Integration of Additional Third-Party SDN Solutions SAN JOSE, Calif.
Sign-up for - Extreme Networks Introduces an Open, Standards Based and Comprehensive SDN and Data Center Ecosystem investment picks
Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. (“Allergan” or “the Company”) (NYSE: AGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc.
Sign-up for - AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - NICE Positioned as a Leader by Gartner in the Magic Quadrant for Customer Engagement Center Workforce Optimization to - AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent